You are here

  • Home
  • Archive
  • Volume 21, Issue 6
  • Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody

Citation Tools

Article menu
Download PDFPDF
Uterine Cancer
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Bellone M, Cocco E, Varughese J, et al
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-αV-Integrin Antibody
International Journal of Gynecologic Cancer 2011;21:1084-1090.